Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 464-471
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.464
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.464
Figure 2 Enrollment outcomes.
1Advanced adenoma: colorectal adenoma or sessile serrated adenoma/polyp ≥ 1.0 cm in diameter; or adenoma with high-grade dysplasia or ≥ 25% villous component, of any size. mt-sDNA: Multitarget stool DNA.
- Citation: Prince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol 2017; 23(3): 464-471
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/464.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.464